Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Preferred Shares (2016)

UroGen Pharma's Preferred Shares history spans 1 years, with the latest figure at $13000.0 for Q4 2016.

  • For Q4 2016, Preferred Shares changed N/A year-over-year to $13000.0; the TTM value through Dec 2016 reached $13000.0, changed N/A, while the annual FY2016 figure was $13000.0, N/A changed from the prior year.
  • Preferred Shares reached $13000.0 in Q4 2016 per URGN's latest filing.
  • In the past five years, Preferred Shares ranged from a high of $13000.0 in Q4 2016 to a low of $13000.0 in Q4 2016.